WA

PIA-STUDY: Probucol in Alzheimer’s Study

Trials / By

Recruiting TAS, SA, WA Summary: Scientists have discovered that a build-up of molecules in the blood may cause damage to brain capillaries, potentially contributing to Alzheimer’s disease. The primary objective of this trial is to evaluate the efficacy of Probucol (Lorelco) on cognitive performance in patients with Alzheimer’s disease (AD) over a 104-week treatment period. […]

PIA-STUDY: Probucol in Alzheimer’s Study Read More »

COLCOT-T2D: COLchicine and non entric coated asprin in the Cardiovascular Outcomes Trial of patients with T2D

Trials / By

Recruiting: WA Summary: People with type 2 diabetes are more likely to develop cardiovascular disease. The COLCOT-T2D trial aims to evaluate the efficacy and safety of colchicine and non enteric-coated aspirin, used either in combination or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes. GP requirements: Identify eligible patients Disseminate study

COLCOT-T2D: COLchicine and non entric coated asprin in the Cardiovascular Outcomes Trial of patients with T2D Read More »

Get in touch

contact us
JOIN
JOIN
Scroll to Top